ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

DCPC Board OKS P01 Grants Program In Nutrition Research

March 11, 1994

House Passes 2.8 Percent Increase For NCI

December 11, 2009

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

April 10, 1981

Daschle Nomination For HHS Secretary Held Up in Senate Finance Committee; Corr Nominated Deputy HHS Secretary

January 16, 2009

Lenalidomide, An Altered Thalidomide, Shows Promise

November 24, 2006